Clinical and Translational Medicine (Oct 2024)
Early postoperative plasma circulating tumour DNA for molecular residue disease detection and recurrence risk evaluation in surgical non‐small cell lung cancer
Abstract
No abstracts available.
Clinical and Translational Medicine (Oct 2024)